JMBM REPRESENTS WEB SERVICE COMPANY IN SALE TO CODE HENNESSY & SIMMONS Jeffer Mangels Butler & Marmaro LLP (JMBM), one of California’s foremost full-service law firms, served as lead transaction counsel for Web Service Company, LLC and its majority owner in its sale to Code Hennessy & Simmons LLC (CHS). The transaction closed on August […]
The Firm successfully represented an aggregate mining operator secure federal and local permits for the largest federally-contracted construction aggregate project in the United States.
The Firm was lead counsel in a successful trial court challenge to school impact fees.
After precedent-breaking litigation, JMBM client, United Rock Products Corporation, and the city of Irwindale, California reached agreement to extend the life of the Irwindale quarries for 25 years. The transaction is most notable for the creation of a joint powers authority between the city of Irwindale and the Irwindale Reclamation Authority. Under the arrangement, the […]
JMBM partners represented a securitized lender — acting by and through GMAC Commercial Mortgage Corporation as special servicer — which was the holder of a $60 million loan secured by a Deed of Trust on the Clift Hotel located in San Francisco, in a Chapter 11 bankruptcy case filed by the Clift Hotel and in […]
JMBM attorneys were able to negotiate federal consent decrees for a regional auto dismantling firm, resolving alleged violations of the Clean Water Act involving 14 separate sites.
On behalf of a family-owned private company JMBM partners negotiated the sale of $150 million in assets in 20 states, completed in 2004 and 2005*.
JMBM attorneys successfully prosecuted an inverse condemnation action against the City of San Diego for regulatory takings of property located in the San Dieguito River Valley.
The Firm represented a construction materials company in defense of a state-court challenge to mining rights for the largest sand and gravel deposit in North America.
JMBM served as legal counsel to Intravenous Therapy Services in the $13 million sale of the company to BioScrip Inc. The Burbank, Calif.-based home infusion pharmaceutical provider will operate under publicly held BioScrip’s infusion division, but will continue to be run by its current president and CEO.